Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trial

Thromb Res. 2026 Mar:259:109631. doi: 10.1016/j.thromres.2026.109631. Epub 2026 Feb 26.
No abstract available

Publication types

  • Letter